Skip to main content
SpringerLink
Log in
Book cover

Anaphylaxis and Hypersensitivity Reactions pp 313–331Cite as

Rapid Desensitizations for Antibiotic-Induced Hypersensitivity Reactions and Anaphylaxis

  • Chapter
  • First Online:

Abstract

Drug-induced anaphylaxis prevents the utilization of antibiotic drugs to patients in need of first-line therapy, including those with cystic fibrosis. Avoidance of antibiotic therapy may be limited by the severity of the infection and the microbial sensitivity. Rapid desensitization for antibiotic-induced drug allergies is the induction of temporary clinical unresponsiveness to antibiotics by gradual reintroduction of small doses of antibiotic until the full antibiotic dose is delivered. Clinical unresponsiveness can be maintained until completion of the antibiotic course by regular administration of the antibiotic allowing safe administration of first-line medications to patients who have presented with hypersensitivity reactions to those medications, including anaphylaxis.

Principles, indications, targets and management of rapid desensitization procedures, including IgE- and non-IgE-dependent hypersensitivity reactions for the most relevant groups of antibiotics, antifungals and antivirals will be reviewed, and rapid desensitization protocols will be addressed for each group.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions inhospitalized patients. JAMA. 279;1998:1200–1205.

    Article  PubMed  CAS  Google Scholar 

  2. Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122(3):574–580.

    Article  PubMed  CAS  Google Scholar 

  3. Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ. Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol. 1982;69(3):275–282.

    Article  PubMed  CAS  Google Scholar 

  4. Hesterberg PE, Banerji A, Oren E, et al. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. J Allergy Clin Immunol. 2009;123(6):1262–1267, e1.

    Article  PubMed  CAS  Google Scholar 

  5. Legere HJ III, Palis RI, Bouza TR, Uluer AZ, Castells MC. A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. J Cyst Fibros. 2009;8(6):418–424.

    Article  PubMed  Google Scholar 

  6. Wendel GD Jr, Stark BJ, Jamison RB, Molina RD, Sullivan TJ. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med. 1985;312(19):1229–1232.

    Article  PubMed  Google Scholar 

  7. Morales AR, Shah N, Castells M. Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen. Ann Allergy Asthma Immunol. 2005;94(5):575–580.

    Article  PubMed  CAS  Google Scholar 

  8. Naclerio R, Mizrahi EA, Adkinson NF Jr. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy and Clin Immunol. 1983;71(3):294–301.

    Article  CAS  Google Scholar 

  9. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371–376.

    Article  Google Scholar 

  10. Simons FE. Anaphylaxis. J Allergy and Clin Immunol. 2008;121(2 Suppl):S402-S407.

    Article  CAS  Google Scholar 

  11. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987;316(26):1622–1626.

    Article  PubMed  CAS  Google Scholar 

  12. Torres MJ, Blanca M, Fernandez J, et al. Selective allergic reaction to oral cloxacillin. Clin Exper Allergy. 1996;26(1):108–111.

    Article  CAS  Google Scholar 

  13. Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008;63(8):1061–1070.

    Article  PubMed  CAS  Google Scholar 

  14. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391–397.

    Google Scholar 

  15. Solensky R. Drug hypersensitivity. Med Clin NA. 2006;90(1):233–260.

    Article  CAS  Google Scholar 

  16. Zhao Y, Qiao H. Detection of specific IgE antibodies to major and minor antigenic determinants in sera of penicillin allergic patients. Chin Med J (Engl). 2003;116(12):1904–1910.

    CAS  Google Scholar 

  17. Castells M. Update on mast cells and mast cell precursors and hypersensitivity responses. Allergy Asthma Proc. 1997;18(5):287–292.

    Article  CAS  Google Scholar 

  18. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr. 1998;132(1):137–143.

    Article  PubMed  CAS  Google Scholar 

  19. Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up. Allergy. 2002;57(12):1151–1158.

    Article  PubMed  CAS  Google Scholar 

  20. Macy E, Mangat R, Burchette RJ. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol. 2003;111(5):1111–1115.

    Article  PubMed  Google Scholar 

  21. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy. 2008;38(1):185–190.

    PubMed  CAS  Google Scholar 

  22. Weiss ME, Adkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy. 1988;18(6):515–540.

    Article  PubMed  CAS  Google Scholar 

  23. Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol. 1982;69(2):238–244.

    Article  PubMed  CAS  Google Scholar 

  24. Sicherer SH. Risk of severe allergic reactions from the use of potassium iodide for radiation emergencies. J Allergy Clin Immunol. 2004;114(6):1395–1397.

    Article  PubMed  CAS  Google Scholar 

  25. Luskin AT, Luskin SS. Anaphylaxis and anaphylactoid reactions: diagnosis and management. Am J Ther. 1996;3(7):515–520.

    Article  PubMed  Google Scholar 

  26. DeSimone JA, Ojha A, Pathak R, Cohn J. Successful desensitization to enfuvirtide after a hypersensitivity reaction in an HIV-1-infected man. Clin Infect Dis. 2004;39(10):e110–112.

    Article  PubMed  Google Scholar 

  27. Dutau H, Saadjian M, Bonneau V, Charpin D. Unsuccessful rapid intravenous desensitization to rifampicin. Allergy. 2000;55(8):778–779.

    Article  PubMed  CAS  Google Scholar 

  28. Takahashi T, Hitani A, Yamada H, Nakamura T, Iwamoto A. Desenitization to fluconazole in an AIDS patient. Ann Pharmacother. 2001;35(5):642–643.

    Article  PubMed  CAS  Google Scholar 

  29. Holland CL, Malasky C, Ogunkoya A, Bielory L. Rapid oral desensitization to isoniazid and rifampin. Chest. 1990;98(6):1518–1519.

    Article  PubMed  CAS  Google Scholar 

  30. Buergin S, Scherer K, Hausermann P, Bircher AJ. Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance. Int Arch Allergy Immunol. 2006;140(1):20–26.

    Article  PubMed  CAS  Google Scholar 

  31. Pruzansky JJ, Patterson R. Desensitization of human basophils with suboptimal concentrations of agonist. Evidence for reversible and irreversible desensitization. Immunology. 1988;65(3):443–447.

    PubMed  CAS  Google Scholar 

  32. Paolini R, Numerof R, Kinet JP. Phosphorylation/dephosphorylation of high-affinity IgE receptors: a mechanism for coupling/uncoupling a large signaling complex. Proc Natl Acad Sci USA. 1992;89(22):10733–10737.

    Article  PubMed  CAS  Google Scholar 

  33. Rubinchik E, Shalit M, Levi-Schaffer F. Responsiveness of human skin mast cells to repeated activation: an in vitro study. Allergy. 1998;53(1):14–19.

    Article  PubMed  CAS  Google Scholar 

  34. Pienkowski MM, Kazmier WJ, Adkinson NF Jr. Basophil histamine release remains unaffected by clinical desensitization to penicillin. J Allergy Clin Immunol. 1988;82(2):171–178.

    Article  CAS  Google Scholar 

  35. Macglashan D, Miura K. Loss of syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol. 2004;114(6):1317–1324.

    Article  CAS  Google Scholar 

  36. Odom S, Gomez G, Kovarova M, et al. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med. 2004;199(11):1491–1502.

    Article  CAS  Google Scholar 

  37. Kepley CL. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol. 2005;138(1):29–39.

    Article  PubMed  CAS  Google Scholar 

  38. Malaviya R, Uckun FM. Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cells. J Immunol. 2002;168(1):421–426.

    PubMed  CAS  Google Scholar 

  39. Shalit M, Levi-Schaffer F. Challenge of mast cells with increasing amounts of antigen induces desensitization. Clin Exp Allergy. 1995;25(9):896–902.

    Article  CAS  Google Scholar 

  40. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1999; 83(6Pt3):665–700.

    Google Scholar 

  41. Simpson AB, Murphy AW, Yousef E. The acceptability of a four-part protocol for penicillin allergy testing by practicing allergists. Allergy Asthma Proc. 2009;30(2):192–201.

    Article  PubMed  CAS  Google Scholar 

  42. Fontaine C, Mayorga C, Bousquet PJ, et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy. 2007;62(1):47–52.

    Article  PubMed  CAS  Google Scholar 

  43. Sanz ML, Gamboa PM, Antepara I, et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy. 2002;32(2):277–286.

    Article  PubMed  CAS  Google Scholar 

  44. Blanca M, Mayorga C, Torres MJ, et al. Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy. 2001;56(9):862–870.

    Article  PubMed  CAS  Google Scholar 

  45. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183–193.

    Article  PubMed  CAS  Google Scholar 

  46. Atanaskovic-Markovic M, Gaeta F, Gavrovic-Jankulovic M, Velickovic TC, Valluzzi RL, Romano A. Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol. 2009;124(1):167–169.

    Article  PubMed  CAS  Google Scholar 

  47. Solensky R. Bloomberg GR, Castells MC, et al. Cephalosporin Administration to Patients With a History of Penicillin Allergy. Immunology. AAoAA ed, 2009.

    Google Scholar 

  48. Solensky R. Drug desensitization. Immunol Allergy Clin North Am. 2004;24(3):425–443,vi.

    Article  PubMed  Google Scholar 

  49. Madaan A, Li JT. Cephalosporin allergy. Immunol Allergy Clin NA. 2004;24(3):463–476, vi-vii.

    Article  Google Scholar 

  50. Ghosal S, Taylor CJ. Intravenous desensitization to ceftazidime in cystic fibrosis patients. J Antimicrobial Chemother. 1997;39(4):556–557.

    Article  CAS  Google Scholar 

  51. Papakonstantinou G, Bogner JR, Hofmeister F, Hehlmann R. Cefotaxime desensitization. Clin Invest. 1993;71(2):165–167.

    CAS  Google Scholar 

  52. Win PH, Brown H, Zankar A, Ballas ZK, Hussain I. Rapid intravenous cephalosporin desensitization. J Allergy Clin Immunol. 2005;116(1):225–228.

    Article  PubMed  CAS  Google Scholar 

  53. Gorman SK, Zed PJ, Dhingra VK, Ronco JJ. Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia. Ann Pharmacother. 2003;37(4):513–516.

    Google Scholar 

  54. Burrows JA, Toon M, Bell SC. Antibiotic desensitization in adults with cystic fibrosis. Respirology. 2003;8(3):359–364.

    Article  PubMed  Google Scholar 

  55. Turvey SE, Cronin B, Arnold AD, Dioun AF. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol. 2004;92(4):426–432.

    Article  PubMed  Google Scholar 

  56. Lin RY. Desensitization in the management of vancomycin hypersensitivity. Arch Intern Med. 1990;150(10):2197–2198.

    Article  CAS  Google Scholar 

  57. Polk RE, Israel D, Wang J, Venitz J, Miller J, Stotka J. Vancomycin skin tests and prediction of “red man syndrome” in healthy volunteers. Antimicrob Agents Chemother. 1993;37(10):2139–2143.

    Article  PubMed  CAS  Google Scholar 

  58. Wong JT, Ripple RE, Maclean JA, Marks DR, Bloch KJ. Vancomycin hypersensitivity: synergism with narcotics and “desensitization” by a rapid continuous intravenous protocol. J Allergy Clin Immunol. 1994;94(2Pt1):189–194.

    Article  PubMed  CAS  Google Scholar 

  59. Kitazawa T, Ota Y, Kada N, et al. Successful vancomycin desensitization with a combination of rapid and slow infusion methods. Intern Med. 2006;45(5):317–321.

    Article  PubMed  Google Scholar 

  60. Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep. 2005;5(1):15–21.

    Article  PubMed  CAS  Google Scholar 

  61. Venturini Diaz M, Lobera Labairu T, del Pozo Gil MD, Blasco Sarramian A, Gonzalez Mahave I. In vivo diagnostic tests in adverse reactions to quinolones. J Investig Allergol Clin Immunol. 2007;17(6):393–398.

    PubMed  CAS  Google Scholar 

  62. Erdem G, Staat MA, Connelly BL, Assa’ad A. Anaphylactic reaction to ciprofloxacin in a toddler: successful desensitization. Pediatr Infect Dis J. 1999;18(6):563–564.

    Article  PubMed  CAS  Google Scholar 

  63. Davila I, Diez ML, Quirce S, Fraj J, De La Hoz B, Lazaro M. Cross-reactivity between quinolones. Report of three cases. Allergy. 1993;48(5):388–390.

    Article  PubMed  CAS  Google Scholar 

  64. Manfredi M, Severino M, Testi S, et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol. 2004;113(1):155–160.

    Article  PubMed  CAS  Google Scholar 

  65. Gea-Banacloche JC, Metcalfe DD. Ciprofloxacin desensitization. J Allergy Clin Immunol. 1996;97(6):1426–1427.

    Article  CAS  Google Scholar 

  66. Lantner RR. Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol. 1995;96(6Pt1):1001–1002.

    Article  PubMed  CAS  Google Scholar 

  67. Schretlen-Doherty JS, Troutman WG. Tobramycin-induced hypersensitivity reaction. Ann Pharmacother. 1995;29(7–8):704–706.

    PubMed  CAS  Google Scholar 

  68. Earl HS, Sullivan TJ. Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol. 1987;79(3):477–483.

    Article  PubMed  CAS  Google Scholar 

  69. Araujo L, Demoly P. Macrolides allergy. Curr Pharm Des. 2008;14(27):2840–2862.

    Article  PubMed  CAS  Google Scholar 

  70. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15(4):716–746.

    Article  PubMed  Google Scholar 

  71. Holmes NE, Hodgkinson M, Dendle C, Korman TM. Report of oral clarithromycin desensitization. Br J Clin Pharmacol. 2008; 66(2):323–324.

    Article  PubMed  Google Scholar 

  72. Cawley MJ, Lipka O. Intravenous linezolid administered orally: a novel desensitization strategy. Pharmacotherapy. 2006;26(4):563–568.

    Article  PubMed  CAS  Google Scholar 

  73. Shahar E, Moar C, Pollack S. Successful desensitization of enfuvirtide-induced skin hypersensitivity reaction. AIDS. 2005;19(4):451–452.

    Article  PubMed  Google Scholar 

  74. Henry RE, Wegmann JA, Hartle JE, Christopher GW. Successful oral acyclovir desensitization. Ann Allergy. 1993;70(5):386–388.

    PubMed  CAS  Google Scholar 

  75. Martinez E, Collazos J, Mayo J. Hypersensitivity reactions to rifampin. Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions. Medicine (Baltimore). 1999;78(6):361–369.

    Article  CAS  Google Scholar 

  76. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328(23):1670–1674.

    Article  PubMed  CAS  Google Scholar 

  77. Dibbern DA Jr, Montanaro A. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann Allergy Asthma Immunol. 2008;100(2):91–100; quiz 3,11.

    Article  PubMed  CAS  Google Scholar 

  78. Bonfanti P, Pusterla L, Parazzini F, et al. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group. Biomed Pharmacother. 2000;54(1):45–49.

    Article  PubMed  CAS  Google Scholar 

  79. Choquet-Kastylevsky G, Vial T, Descotes J. Allergic adverse reactions to sulfonamides. Curr Allergy Asthma Rep. 2002;2(1):16–25.

    Article  PubMed  Google Scholar 

  80. Leoung GS, Stanford JF, Giordano MF, et al. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. J Infect Dis. 2001;184(8):992–997.

    Article  PubMed  CAS  Google Scholar 

  81. Caumes E, Guermonprez G, Lecomte C, Katlama C, Bricaire F. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Arch Dermatol. 1997;133(4):465–469.

    Article  PubMed  CAS  Google Scholar 

  82. Carr A, Penny R, Cooper DA. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS. 1993;7(1):65–71.

    Article  PubMed  CAS  Google Scholar 

  83. Nguyen MT, Weiss PJ, Wallace MR. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients. AIDS. 1995;9(6):573–575.

    Article  PubMed  CAS  Google Scholar 

  84. Solensky R. Drug desensitization. Immunol Allergy Clin NA. 2004;24(3):425–443,vi.

    Article  Google Scholar 

  85. Demoly P, Messaad D, Sahla H, et al. Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. J Allergy Clin Immunol. 1998;102(6Pt1):1033–1036.

    Article  PubMed  CAS  Google Scholar 

  86. White MV, Haddad ZH, Brunner E, Sainz C. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Ann Allergy. 1989;62(3):177–179.

    PubMed  CAS  Google Scholar 

  87. Craig TJ, Peralta F, Boggavarapu J. Desensitization for fluconazole hypersensitivity. J Allergy Clin Immunol. 1996;98(4):845–846.

    Article  PubMed  CAS  Google Scholar 

  88. Douglas R, Spelman D, Czarny D, O’Hehir R. Desensitization to itraconazole. J Allergy Clin Immunol. 1997;99(2):269.

    PubMed  CAS  Google Scholar 

  89. Bittleman DB, Stapleton J, Casale TB. Report of successful desensitization to itraconazole. J Allergy Clin Immunol. 1994;94(2Pt1):270–271.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA

    Mariana C. Castells

Authors
  1. Tito Rodriguez Bouza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ross I. Palis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henry J. Legere III
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mariana C. Castells
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariana C. Castells .

Editor information

Editors and Affiliations

  1. Harvard Medical School, Ambulatory Center, Brigham and Women’s Hospital, Boyleston Street, Route 9 850, Chestnut Hill, 02467, Massachusetts, USA

    Mariana C. Castells

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bouza, T.R., Palis, R.I., Legere, H.J., Castells, M.C. (2011). Rapid Desensitizations for Antibiotic-Induced Hypersensitivity Reactions and Anaphylaxis. In: Castells, M. (eds) Anaphylaxis and Hypersensitivity Reactions. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-951-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-951-2_20

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-950-5

  • Online ISBN: 978-1-60327-951-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation